Proliferating neural stem cells and intermediate progenitors persist in the ventricular-subventricular zone (V-SVZ) of the adult mammalian brain. This extensive germinal layer in the walls of the lateral ventricles is the site of birth of different types of interneurons destined for the olfactory bulb.. The cell cycle dynamics of stem cells (B1 cells), intermediate progenitors (C cells) and neuroblasts (A cells) in the V-SVZ, and the number of times these cells divide remain unknown. Using whole mounts of the walls of the lateral ventricles of adult mice and three cell cycle analysis methods using thymidine analogs we determined the proliferation dynamics of B1, C and A cells in vivo. Ascl1+ C cells were heterogeneous with a cell cycle length (TC) of 18-25 hrs and a long S phase (TS) of 14-17 hrs. After C cells, Doublecortin+ A cells were, the second most common dividing cell type in the V-SVZ, and had a TC of 18 hrs and TS of 9 hrs. hGFAP::GFP+ B1 cells had a surprisingly short TC of 17-18 hrs and a TS of 4 hrs.
Introduction
Neurogenesis continues along the walls of the lateral ventricle in the adult rodent brain. Neural stem cells correspond to a subpopulation of local astrocytes (B1 cells) (1), (2) , (3) , which retain an apical contact with the ventricle. Therefore, this adult germinal layer includes not only a subventricular component, but also a ventricular zone; i.e. ventricular-subventricular zone (V-SVZ) (4) . B1 cells give rise to intermediate progenitors, or transit amplifying cells (C cells), which divide to generate neuroblasts (A cells) that continue to proliferate (5) , (6) (7) and migrate tangentially along the rostral migratory stream to the olfactory bulb, a process of continuous neuronal replacement that occurs throughout life (8) , (9) , (10) .
While the lineage in the V-SVZ has been determined, the cell cycle dynamics of each cell population remain unknown. An essential amplifying stage within the lineage is the proliferation of C and A cells. Small changes in the cell cycle length or number of times these intermediate precursors divide could result in significant changes in the number of neurons produced. Previous studies estimated cell cycle dynamics for all dividing cells, assuming a homogeneous population. Moreover, the calculated length of the cell cycle (TC) for all V-SVZ cells vary in different publications from 13-14 hrs (11) or 18-21 hrs. (12) , (13) , (14) .
Length of the S phase (TS) as short as 4 hrs (11) or as long as 8.5-13 hrs (12), (13) , (14) has also been reported. These variabilities might be explained not only by the pooling of all proliferating V-SVZ cells, but also because these previous studies are based on the analysis of tissue sections. Neuroblasts continue to divide as they actively migrate tangentially (5) , (15) Therefore dividing cells move in and out the counting bin in coronal or sagittal sections likely introducing errors in the analysis (16) .
Here, we estimated the cell cycle dynamics of V-SVZ progenitors in vivo ( Fig. 4, 5) using multiple methods and a whole mount preparation that does not require sectioning (17) . The spatial localization of neural stem cells determines the subtypes of olfactory bulb interneurons produced (18) (19) ; however, we found that the cell cycle dynamics were very similar across different subregions of the V-SVZ ( Fig. S2G-J) . Interestingly, our results indicate that actively dividing neural stem cells had a surprisingly short S phase. C cells had a much longer TS and their cell cycle dynamics were heterogeneous. Our data further indicate that in each lineage tree, C cells divided approximately three times and A cells once or twice. This analysis reveals the in vivo dynamics of cell proliferation and neuronal production in this major adult germinal layer.
Results

Overall Estimates of Cell Types Dividing in the Adult V-SVZ
To label dividing cells during S phase we used thymidine analogs 5-chloro-2'-deoxyuridine (CldU) (20) , (21) and 5-ethynyl-2'-deoxyuridine (22) which we found can be readily detected with similar sensitivity and without cross-reactivity (see suppl. mat.) However, we observed that EdU had long-term toxicity (see Three markers were used for identification of the different proliferating progenitors in the V-SVZ: GFAP for B1 cells, Ascl1 for C cells (23) , and DCX for A cells (24) . Since GFAP antibodies primarily stain the processes of B1 cells, we used hGFAP::GFP mice (25) , (26) , which express green fluorescent protein under the control of the human GFAP promoter ( Fig. 1A , S1B-I). In these mice, a small fraction (1.90+/-0.15%, n=14) of all GFP labeled cells also stained for Ascl1.
Conversely, a small subpopulation (3.07+/-0.57%; Fig. 1D ) of Ascl1+ cells were also positive for GFP. This population could correspond to a transitional stage in the lineage (27) , (28) or to a population of long-term self-renewing neural stem cells that express Ascl1 (29) , or both. The expression of Ascl1 was also retained in a subpopulation of DCX+ cells: 15.87+/-1.64% of the Ascl1+ cells were DCX+ (10.67+/-3.12% of DCX+ cells were Ascl1+, n=3).
We first determined the number of cells of the different types in the S phase using V-SVZ whole mounts. Following a single injection of EdU (30' survival), GFP+ cells accounted for 3.92+/-0.91%, (n=5), Ascl1+ for 40.06+/-1.78%, (n=4); and DCX for 35.79+/-2.09% (n=3) of EdU+ cells ( Fig.1D -G). We next quantified the percentage of mitotic cells (identified by pHH3 staining) among hGFAP::GFP+, Ascl1+, and DCX+ cells. Consistent with the EdU labeling, the majority of pHH3+ cells in the V-SVZ corresponded to Ascl1+ (45.89+/-0.08%, n=60) and DCX+ (45.57+/-2.66%; n=7) cells. hGFAP::GFP+pHH3+ were less common (4.80+/-0.45%, n=20; Fig.1D ,H-L). Since quantifications of proliferating cells based on EdU incorporation or pHH3 staining may be affected by the length of TS and TM with respect to TC, we also stained whole mounts with Ki67, a proliferation marker that is expressed throughout most of the cell cycle except G0 (30) . We found that for all Ki67+ cells, 54.01+/-3.22% were Ascl1+, 53.52+/-2.54% were DCX+ and 3.30+/-0.95% were GFP+ (in hGFAP::GFP mice).
Together, these results indicate that in the adult V-SVZ proliferating Ascl1 and DCX+ cells are both much more common than dividing hGFAP::GFP+ cells.
We also counted the number of pHH3 or EdU (30' survival) labeled Ascl1 and hGFAP::GFP+ cells during different times of day and night ( Fig. S2A -E and suppl. mat.). We found that the rate of proliferation for these two populations in the V-SVZ cells remained relatively constant with the circadian rhythm.
Actively Dividing hGFAP::GFP Cells Complete the Cell Cycle in Less than a
Day
B1 cells: Cumulative Labeling Method (CL).
hGFAP::GFP mice received 1 to 16 injections of EdU (one injection every 2 hrs) and were sacrificed 30' after the last injection. The total number of GFP+ cells remained constant at all survival times studied, indicating that EdU injections did not affect the total number of GFP+ cells within the V-SVZ (Fig. 2 ).
The labeling index (LI: the number of double labeled cells divided by the total number of GFP+ cells; n=5) progressively increased up to 14 hrs, reaching a plateau with a LI of y=0.08610. This corresponds to the growth fraction (GF), indicating that 8.6% of the GFP+ population is actively proliferating ( Fig. 2A -E).
The data ( Fig. 2D ) can be described by two regression lines: "a" the linear increase in cell labeling between 30' and 14 hrs (y=0.00486x+0.02186); "b" the horizontal line between 14 and 24 hrs. The time (in the x axis) when the two regression lines intersect equals TC minus TS = 13.22 hrs. The intersect of line "a" with the y axis is defined as the initial labeling index (LI0) and corresponds to GF x TS/TC (16) (31) . For our data, LI0 was 0.022. From these three equations we calculated a TC of 17.73 hrs and a TS of 4.50 hrs for GFP+ cells. Since the plateau (the intersect between lines a & b) is reached when all dividing GFP+ cells have incorporated EdU, this method over-represents the population of cycling cells with the slowest TC (32), (33) . For this reason, 17.73 hrs is likely a reflection of the GFP+ cells that take the longest time to complete the cell cycle.
B1 cells: Double Thymidine Analog Method (DA).
We next employed the DA method (31), (32) to determine TS for the GFP+ cells. We labeled GFP+ cells in S phase with an initial injection of CldU followed 2 hrs later by an injection of EdU and a final survival of 30' ( hGFAP::GFP mice received a single injection of CldU and were analyzed at survivals ranging between 30' and 8 hrs for the number of triple-labled (GFP+pHH3+CldU+) cells. Given the low number of GFP+pHH3+ B1 cells in our material, we only analyzed the period from the initial appearance of mitotic B1 cells to the time when all of these cells were triple-labeled. No triple labeled cells were observed at 30' suggesting that TG2 >/= 30'. As CldU+GFP+ cells completed G2, the number of mitotic GFP+pHH3+CldU+ cells increased reaching 100% by 6 hrs (Fig. S1W ). This indicates that TG2+TM for hGFAP::GFP cells is </= 6 hrs. We did not use the PLM method to estimate TC and TS for B1 cells (see discussion). 
Ascl1+ Cells are Heterogeneous in their Cell Cycle Dynamics
C cells: CL method
Wild type mice received 1 to 10 injections of EdU (separated by 2 hrs intervals; n=5 for each time point) and were sacrificed 30' after the last injection (see progressively increased up to 10 hrs before reaching a plateau. We used two regression lines (a & b) and calculated the GF, LI0 and TC-TS ( Fig. 3A -D) using the same method as indicated above for hGFAP::GFP cells. The GF (87.11+/-0.46%) calculated by the CL was similar to the ratio of Ascl1+Ki67+/Ascl1+ cells (89.15+/-1.72%, p=0.47, n=5). Using the equations described above for the hGFAP::GFP+ cells, we calculated for the Ascl1+ population a TC=25.44 hrs and TS =14.80 hrs.
C cells: DA method
Mice received one injection of CldU followed by an injection of EdU 3 hrs later. using the CL method, these data show that Ascl1+ cells have a long TS. Given how long C cells remain in the S phase this method may overestimate TS. We therefore used an additional method to determine cell cycle dynamics for the Ascl1 population.
C cells: percent of labeled mitosis (PLM).
In order to estimate TS and TC with a different approach and determine TG2, TM and TG1 we used the PLM method (33) . 
Neuroblasts Continue to Divide with Cell Cycle Dynamics Similar to those of Fast Cycling C Cells
We next investigated the cell cycle parameters of the DCX+ cells (neuroblasts, A cells). It has been previously shown that A cells continue to divide while migrating (15), (36); we observed that 54.63% (+/-1.26; n=3) of the DCX+ cells were positive for Ki67 ( Fig. 1 ).
Since A cells migrate rapidly away from the walls of the ventricle into the dorsolateral corner of the V-SVZ and into the rostral migratory stream, the proportion of labeled cells within our counting bin changes over time. For this reason, methods that employ long survivals (CL and long-term PLM) cannot be reliably used to calculate cell cycle dynamics of A cells (16) . We therefore used strategies that use short survivals: the DA method and a short version of the PLM technique. The ratio of DCX+EdU+ cells to DCX+Ki67 cells equals the ratio of TS to TC.
We estimated this ratio for each animal (0.48; 0.56; 0.38) and calculated the average TC = 17.85+/-3.24 hrs
A cells: PLM short method
We analyzed the initial appearance of mitosis among cells that had incorporated CldU following a single injection (50 mg/kg). The number of mitotic (pHH3+) CldU+DCX+ triple-labeled cells was determined after 30', 1, 2, 3, 4 and 6 hrs (n=3 each time point). 30' after injection, we did not observe any DCX+ cells that were labeled by CldU (0 out of 47 DCX+pHH3+ cells counted, n=4). In contrast, the majority of DCX+pHH3+ cells were CldU+ at 5 and 6 hrs post injection (88.10+/-7.90 and 88.54+/-6.93%, respectively). From the slope of the regression line before reaching the plateau (first 4 values), we determined:
TG2=0.89 hrs and TM=3.97 hrs ( Fig.4B ). Thus, neuroblasts had a TC, TG2 and TM similar to that of C cells, but had a shorter S phase and a longer G1 phase.
Intermediate Progenitors of the V-SVZ Divide on Average 3-4 Times
Amplification in the V-SVZ lineage is critically dependent on the number of times intermediate progenitors divide. Our PLM analysis suggests that some C cells divide at least two times and possibly three, but given the heterogeneity in TC it is difficult to determine if additional divisions occur ( Fig. 3) . Most Ascl1+CldU+ cells were also labeled by EdU when the interval between the two injections was 2 hrs (Fig. 5G ). The number of Ascl1+CldU+EdU-cells increased as the cohort of CldU+ cells exited the S phase. Between 10 and 22
hrs, the number of Ascl1+CldU+EdU-, cells decreased as proliferating progenitors re-entered the S phase and incorporated EdU. This time (22 hrs) is similar to the average TC of Ascl1+ cells determined above. Within the first three days, three troughs corresponding to sequential S phases could be detected (black arrows in Fig. 5G ), and possibly a fourth one at day 4 (grey arrow in Fig. 5G ). These data again indicate that C cells divide, with a cell cycle just short of one day, three to four times. However, one division is likely due to labeling of B1 cells that upon division gave rise to CldU+ Ascl1+ C cells.
Discussion
Our results indicate that the TC for the three main progenitor cells in the adult V-SVZ of adult mice was slightly shorter than one day (B1 cells: 17hrs; C cells: ~18-25hrs; A cells: 18hrs; Fig. 6 ), but the TS for the actively dividing B1 cells was surprisingly short (4.5 hrs) compared to that of C cells (12-17 hrs) and A cells (9 hrs; Fig. 6 ). In this study we only analyzed actively dividing GFAP+ cells. We cannot exclude that there is a population of quiescent B1 cells with a longer TC possibly associated with periods of quiescence (37) . Interestingly, the short S phase and long G1 phase of the actively dividing B1 cells is similar to that of radial glia (38) , the neural stem cells in development and the precursors of B1 cells (39) . Our results suggest that following the initial division of GFAP+ B1 cells, Ascl1+ C cells divide 3 times before turning into DCX+ A cells. Since A cells actively migrate as they divide, it is difficult to determine how many times they undergo cell division; our results suggest they may divide once or twice before leaving the V-SVZ.
Tools for Studying the Cell Cycle Dynamics and their Limitations
Thymidine analogs have been instrumental to identify and follow the division of neural progenitors in the adult brain, but these analogs may label cells undergoing DNA repair or cell death (40) , (41) . Most, if not all, of the labeling we observed following EdU or CldU injections was associated with proliferation since:
1) at short survivals (30') EdU and CldU labeled similar ratios of the different cell types (hGFAP::GFP, Ascl1 and DCX) as mitotic marker pHH3 and proliferation marker Ki67; 2) the population of dividing Ascl1+ cells was similar using cumulative EdU labeling or Ki67. Toxicity for CldU or EdU was not observed at short survival times, consistent with previous reports (42) . However, at longer survival times the numbers for CldU-labeled cells were much higher compared to cells that incorporated EdU (Fig. S1B-I) . This suggests that EdU is toxic at longer survivals. Consistently, pyknotic nuclei were common among V-SVZ cells one day after EdU treatment, but not in mice injected with CldU ( Fig. S1B-I) . Toxic effects of EdU, but not CldU, were also observed in primary cultures from V-SVZ 24 hrs after treatment ( Fig. S1B-I) . We therefore used EdU only in experiments shorter than 18 hrs and CldU in experiments that extended beyond the first cell cycle.
The estimation of cell cycle dynamics requires that dividing cells remain in the counting bin for the duration of the experiment (16) ; this condition is not met in sectioned brain tissue as A cells actively migrate tangentially. Earlier studies applying the CL method for the total dividing V-SVZ population in neonate (43) and adult mice report a shorter TC of 12-14 hrs (11) compared to the present results and others' data (12) , (14) , (44) . Those differences are likely due to the use of tissue sections in different planes, the migration of neuroblasts, and the heterogeneous nature of progenitors. We have attempted to overcome some of these limitations by the use of V-SVZ whole mounts. The en-face view allows inclusion of a larger bin in a tangential plane. However, we can only reduce, but cannot eliminated the effects of migration of neuroblasts, as a subpopulation of these cells is constantly moving away from V-SVZ into the rostral migratory stream. For these reasons we employed only short survival methods (DA and first ascending slope in PLM) for the cell cycle analysis of A cells.
Identification of Dividing Progenitors in the Adult V-SVZ.
Precise estimates of cell cycle dynamics in the adult V-SVZ require identification of the different types of dividing progenitors We have used hGFAP::-GFP mice to identify B1 cells and immunostaining for Ascl1 and DCX to label C and A cells, respectively (23), (26) , (45) . Most of the proliferating hGFAP::GFP+ astrocytes within the V-SVZ are,neural stem cells (1), (46) and express other astrocytic markers, such as Glast (47) and AldH1-L1 (48) .
hGFAP::GFP mice reporter protein was more reliable for quantification of B1 cells than GLAST::DsRed, (49) and AldH1-L1::GFP (50) ( Fig. S1J-V) . However, among the cells identified with any of these markers, including the hGFAP-GFP mice, there is also a small population of V-SVZ astrocytes that are nonneurogenic, and we cannot exclude possible effects of this population from our analysis.
Since in our study, the majority of cells studied correspond to singly-labeled populations, we believe that our data reliably reflect the cell cycle dynamics of major progenitor stages in the V-SVZ. However, progenitor cells are dynamic and constantly drifting to a new stage of differentiation and therefore stable progenitor stages may not exist in vivo, possibly explaining some of the heterogeneity we observe (see below). Consistently, we observed a few cells that express markers for two cell types, hGFAP::GFP and Ascl1 (B1 and C cell markers) or Ascl1 and
DCX (C and A cells). The population of cells double-labeled by hGFAP::GFP and
Ascl1 was small (<3%). In "knock-in" Ascl1::Cre ER T2/+ mice, the reporter is expressed mainly in intermediate progenitors and in a small subset of neural stem cells (29) . In another study, 36% of GFAP+EGFR+ cells are found faintly Ascl1+, Ascl1, which activates expression of the proneurogenic program, also has pivotal roles in promoting the G1-S and G2-M transitions (23), (51) . During development Ascl1 and Hes1 oscillate in opposite directions during cell cycle with high Hes1 expression in G1 (52) . If Ascl1 also fluctuates in the adult V-SVZ, the fraction of C cells labeled by Ascl1 may vary along the cell cycle and we may have underestimated the total population of C cells. This may also explain the short G1 in our PLM estimates (Fig. 6 ). The TC of C cells may, thus, be somewhat longer than calculated.
Origin of C Cell Cycle Heterogeneity
Our data indicate that C cells are heterogeneous with a TC that varied between 
Cell Cycle Dynamics and Lineage Progression
Our data suggest that following the division of B1 cells, there are 3 amplifying divisions associated to the proliferation of C cells, and 1 or 2 divisions associated to the division of A cells (Fig. 6 ). From our estimated cell cycle transit time, the generation of the initial C cells can occur in less than a day with the following amplification of C cells completed in 3.5-4 days. Consistent with previous reports (5), (6), (7) , an important fraction of the proliferating cells in the V-SVZ corresponded to A cells. The additional division(s) of these neuroblasts further amplifies the number of new neurons as illustrated in Fig. 6 . If A cells divide once or twice, it should take an additional 17-40 hrs to complete the lineage. This is a total of 4-6 days from the initial division of a B1 cell to the generation of postmitotic young neurons. This is consistent with the observations that during regeneration following antimitotic treatment, A cells are first observed at 4.5 days (54), and following a single CldU injection, the majority of proliferating cells leaves the V-SVZ after 6-7 days (Fig. 5 ).
The GF for hGFAP::GFP cells was 8.6%; these cells likely correspond to the population of activated B1 cells (28) . We counted a total of 6200+/ Consistent with our observations, a recent in vitro study suggests that slowly dividing primary astroglial progenitors divide asymmetrically to generate actively dividing cells that continue to express astroglial markers (53) . The latter likely corresponds to the activated hGFAP::GFP cells we studied here. Costa et al.
(53) also found approximately 5 stages of amplification, which should result in similar numbers of generated A cells from activated B1 cells as calculated above.
It is interesting that the behavior of isolated progenitors in vitro, without exposure to growth factors, is so similar to that inferred here in vivo, further supporting the view that lineage progression may be largely cell-autonomously determined (53) .
As discussed above, the average TC for Ascl1+ cells was slightly longer than the average TC for B1 and A cells. TM and TG2 were, however, comparable for all three types of progenitors. Interestingly, C cells had a TS 3.5-4.3 fold as long as that of B1 cells and 1.4-2.1 fold longer than that of A cells (Fig. 6B ). Pluripotent stem cells and immortalized cell lines also have proportionally longer TS (58) .
Checkpoints in G1 and S phases prevent the replication of damaged DNA (59) and slow down S phase progression (60) . (65); a short TG1 may favor proliferation (68) while lengthening of G1 may trigger differentiation (69) . This is consistent with our observation that C cells have a very short TG1, likely related to their repeated divisions before they begin neural differentiation into A cells.
Concluding Remarks
This study provides fundamental information to understand lineage progression from neural stem cells to their progeny in the adult brain. The study reveals a number of unexpected observations; a subpopulation of B1 cells was actively dividing, with a relatively short cell cycle compared to that of intermediate progenitors, C cells, which have long S and short G1 phases. The work also highlights the importance of neuroblast division for the overall high number of new neurons produced in the adult V-SVZ. This also explains why A cells account for almost half of all actively dividing cells (Fig. 6 ). It is reassuring that our cell cycle estimates predict quite accurately the overall number of different types of dividing progenitors observed at any one time, the overall progression from one stage to the next, the total number of young neurons produced, and the timing of clearance of dividing cells from the V-SVZ as neuroblasts move into the rostral migratory stream and olfactory bulb. The cell cycle progression described here for the different progenitor cells provides an important new understanding of how neurogenesis is maintained in the adult brain.
Material and Methods
Animals Mice were housed and treated according to the guidelines from the UCSF Laboratory Animal Care and Use Committee. 376 2-month-old male C57/BL6 (Charles River) mice were used for all the controls of the DA and the study of C and A cells. For B1 cell analysis, we used 109 hGFAP::GFP mice (FVB/N-TgGFAPGFP14Mes/J; Jackson Labs). This many animals were required because from each animal only two whole mount preparations can be obtained.
Whole mount preparation Mice were deeply anesthetized with 2.5% tribromoethanol (Avertin), and perfused transcardially with 0.9% NaCl. Brains were removed, the lateral and medial ventricular walls were immediately dissected out in warm Leibovitz's L15 medium as previously published (3), (17), (70) . In all the experiments described here, whole mounts were fixed in 4% PFA, 0.1% Triton for 6hrs, then kept in PBS-Sodium azide at 4°C until immunohistochemical processing.
Whole mounts were incubated for 48 hrs at 4°C with primary antibodies, followed by 48hrs at 4°C with the appropriate secondary antibodies (Tab. S1).
For mounting, whole mounts were then further dissected and embedded with Aqua Poly/Mount mounting medium (Polysciences Inc., Warrington PA). were analyzed for each hemisphere (Fig. S1A ).
Double and triple labeled cells were counted tri-dimensionally using the Imaris software (Imaris, Bitplane, CH). All values are expressed as number of cells/mm 2 or as ratios.. Data were analyzed by Student's t-Test, with a value of p≤0.05 considered statistically significant.
Thymidine analogs CldU (5-Chloro-2′-deoxyuridine; Sigma) and EdU (5-ethynyl-2'-deoxyuridine; Invitrogen) were dissolved at 10 mg/ml in sterile PBS and administered by an intraperitoneal injection. Since their molecular weight is similar (CldU 262.65 g/mol and EdU 252.22 g/mol) we used the same dose of 50 mg/kg for both analogs.
For CldU labeling, samples were pretreated with formamide SSC (20) , denatured with 0.5 M of hydrochloric acid for 30' at 37°C, washed with boric buffer for 10' and processed for rat anti-BrdU antibody staining (Tab. S1). EdU was detected using a commercial kit (Invitrogen) at the end of the immunohistochemical reactions.
(a) For in vivo controls, mice received subsequently one injection of CldU and one of EdU two hrs later or vice versa, and were sacrificed after 30'.
Alternatively, mice received either one injection of CldU or EdU, or both (50mg/kg), 30' before fixation. Whole mounts were prepared and stained as explained above. The average number of cells/mm 2 labeled by EdU was compared with the counts for CldU labeling. Both analogs had the same efficiency with little or no cross-reaction between them.
Moreover, to ensure that the labeling with CldU did not impair the ability of cells to incorporate EdU 2hrs later, we counted the number of EdU labeled cells 30' after the injection in mice that received only EdU to mice previously treated with CldU.
(b) Evaluation of the toxicity of thymidine analogues: Primary cultures were prepared from the V-SVZ from mice that received EdU in vivo 1 hr before the dissection, and analyzed for EdU-labeling 2 hrs and 24 hrs later, but not from CldU treated mice. Plates were fixed 2 hrs and 24 hrs later and stained for either CldU or EdU. In addition, C57/BL6 mice received either one injection of CldU or EdU (50mg/Kg), and were killed at different time points. Whole mounts were processed as described above. The number of labeled cells was counted along with the number of labeled Ascl1+ cells ( Fig. S1B-I) .
Cell cycle determination All the cell cycle analysis experiments started at 9 AM.
(a) CL method: 2-months-old mice (C57/BL6; hGFAP::GFP) received 1 to 16 repeated injections of EdU (50mg/kg, one every 2hrs). Two hrs is shorter than the S phase for V-SVZ cells (see results), assuring that all V-SVZ cells dividing during the experiment would be labeled by EdU (16) . Mice were killed 30' after the last injection, and the lateral and medial wall of the lateral ventricle were dissected. Whole mounts were stained for either GFP or Ascl1 and EdU (as described above).
For each time point, 5 mice (10 hemispheres) were analyzed. EdU+, GFP+ (or Ascl1+) and double-labeled cells within 5 subregions of the V-SVZ (Fig. S1A) were acquired in z-stacks with the confocal microscope and quantified using Imaris software.
The labeled fraction of a population (number of hGFAP::GFP+EdU+ or Ascl1+EdU+ cells divided by the total number of hGFAP::GFP+ or Ascl1+ cells, respectively) was counted and the labeling indexes (16) were determined and averaged for each survival time. CL data can be described by two regression lines: a) least squares fit lines through the data points prior the plateau of LI; b) the plateau y=GF ( Fig. 2A-E; 3A-D) . The intersect of the first regression line with the y axis is defined as the initial labeling index (LI0) and corresponds to (GFxTS)/TC (16) , (34) . The time (x axis) at which the plateau is reached (when the two regression lines intersect) equals TC minus TS.
By resolving the two equations a) and b) we calculated TC and TS. (c) PLM method: Mice received a single injection of 50mg/Kg CldU and whole mounts were prepared after different time points (hGFAP::GFP mice were sacrificed at 30', 2, 4, 6, and 8 hrs; C57/BL6 mice were sacrificed at 30', 2, 4, 6, 8, 10,12,14,16,18, 20, 22, 24, 26, 28, 30, 36, 42, 48, 54, 60, 66 , 72 hrs after CldU injection; (Fig. 3G-K; 4C-E; S1W). For each population (B1, C, A cells) the number of mitotic (pHH3+) cells and mitotic CldU+ cells were measured for each time point. Nuclei with a homogeneous staining for pHH3 were counted as labeled mitosis (Fig. 3H ). Nuclei with few bright discrete dots of nuclear pHH3 labeling were not counted as these correspond to cells that are still in the G2 phase (71) .
For each cell type we calculated the ratio of CldU+ labeled mitoses to the total number of mitoses (e.g. Ascl1+CldU+pHH3+/Ascl1+pHH3+) for each time point. The values of this time course were plotted and described by regression lines.
By calculating the least square fit for the ascending, plateau, and descending lines, we can calculate (33) Fig S1W) . 
Figure legends
